MedTrace Logo

Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

NCT00699322 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2009-10-29

No results posted yet for this study

Summary

This research will focus on the effect of Sitagliptin on 24 hour glycemic excursion and improvement of oxidative stress markers compared to long acting sulphonylurea Glimepiride in type 2 diabetic patients with inadequate glycemic control on metformin

Conditions

Interventions

DRUG

Sitagliptin

100mg P.O. per day for 1month

DRUG

Glimepiride

2mg P.O. per day for 1 month

Sponsors & Collaborators

  • MSD Korea Ltd.

    collaborator INDUSTRY

  • The Catholic University of Korea

    lead OTHER

Principal Investigators

  • Kun-Ho Yoon, M.D., Ph.D. · Kangnam St.Mary's hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00699322 on ClinicalTrials.gov